EUVIMEDExplore EUVIMED
Crossref

Assessing the influence of graft loss on 4‐year patient survival after simultaneous pancreas‐kidney transplantation: Kaplan–Meier versus Competing Risk Analysis model

Lucia Alejandra Alfaro Villanueva iD, Roberto Meirelles Junior iD, Érika Bevilaqua Rangel iD, Luis Gustavo Modelli iD, Laila Almeida Viana iD, Marina Pontello Cristelli iD, Lúcio Requião-Moura iD, Renato Demarchi Foresto iD, Helio Tedesco-Silva iD, José Medina Pestana iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15298 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Lucia Alejandra Alfaro Villanueva and 9 co-authors. Institution: Hospital do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil. Major MEDLINE topics: Diabetes Mellitus, Type 1, Kidney Transplantation, Pancreas Transplantation. Cited 1 times so far (Crossref); 29 references. Funded by: Coordenação de Aperfeiçoamento Pessoal de Nível Superior, Brasil (CAPES), Finance Code 001..

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Background

Graft loss increases the risk of patient death after simultaneous pancreas‐kidney (SPK) transplantation. The relative risk of each graft failure is complex due to the influence of several competing events.

Methods

This retrospective, single‐center study compared 4‐year patient survival according to the graft status using Kaplan‐Meier (KM) and Competing Risk Analysis (CRA). Patient survival was also assessed according to five eras (Era 1: 2001–2003; Era 2: 2004–2006; Era 3: 2007–2009; Era 4: 2010–2012; Era 5: 2012–2015).

Results

Between 2000 and 2015, 432 SPK transplants were performed. Using KM, patient survival was 86.5% for patients without graft loss ( n = 333), 93.4% for patients with pancreas graft loss ( n = 46), 43.7% for patients with kidney graft loss ( n = 16), and 25.4% for patients with pancreas and kidney graft loss ( n = 37). Patient survival was underestimated using KM versus CRA methods in patients with pancreas and kidney graft losses (25.4% vs. 36.2%), respectively. Induction with lymphocyte depleting antibodies was associated with 81% reduced risk (HR.19, 95% CI.38–.98, p = .0048), while delayed kidney function (HR 2.94, 95% CI 1.09–7.95, p = .033) and surgical complications (HR 2.94, 95% CI 1.22–7.08, p = .016) were associated with higher risk of death. Four‐year patient survival increased from Era 1 to Era 5 (79% vs. 87.9%, p = .047).

Conclusion

In this cohort of patients, kidney graft loss, with or without pancreas graft loss, was associated with higher mortality after SPK transplantation. Compared to CRA, the KM model underestimated survival only among patients with pancreas and kidney graft losses. Patient survival increased over time.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1Kidney TransplantationPancreas TransplantationHumansRetrospective StudiesRisk AssessmentPancreasGraft Survival

Author keywords

Competing Risk Analysis ModelKaplan‐Meier methodSimultaneous pancreas‐kidney transplantationkidney graft losspancreas graft lossrecipient survival

Authors and institutions

  • Hospital do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil.
  • Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Division of Nephrology, Department of Internal Medicine, Universidade Estadual Paulista (UNESP), Botucatu, Brazil.

ORCID profiles: Lucia Alejandra Alfaro Villanueva, Roberto Meirelles Junior, Érika Bevilaqua Rangel, Luis Gustavo Modelli, Laila Almeida Viana, Marina Pontello Cristelli, Lúcio Requião-Moura, Renato Demarchi Foresto, Helio Tedesco-Silva, José Medina Pestana

Funding

  • Coordenação de Aperfeiçoamento Pessoal de Nível Superior, Brasil (CAPES), Finance Code 001.

Cite

APA

Alfaro Villanueva, L. A., Junior, R. M., Rangel, É. B., Modelli, L. G., Viana, L. A., Cristelli, M. P., Requião-Moura, L., Foresto, R. D., Tedesco-Silva, H., & Pestana, J. M. (2024). Assessing the influence of graft loss on 4‐year patient survival after simultaneous pancreas‐kidney transplantation: Kaplan–Meier versus Competing Risk Analysis model. Clinical Transplantation. https://doi.org/10.1111/ctr.15298

Vancouver

Alfaro Villanueva LA, Junior RM, Rangel ÉB, Modelli LG, Viana LA, Cristelli MP, et al. Assessing the influence of graft loss on 4‐year patient survival after simultaneous pancreas‐kidney transplantation: Kaplan–Meier versus Competing Risk Analysis model. Clinical Transplantation. 2024. doi:10.1111/ctr.15298

BibTeX
@article{AlfaroVillanueva2024,
  author = {Alfaro Villanueva, Lucia Alejandra and Junior, Roberto Meirelles and Rangel, Érika Bevilaqua and Modelli, Luis Gustavo and Viana, Laila Almeida and Cristelli, Marina Pontello and Requião-Moura, Lúcio and Foresto, Renato Demarchi and Tedesco-Silva, Helio and Pestana, José Medina},
  title = {Assessing the influence of graft loss on 4‐year patient survival after simultaneous pancreas‐kidney transplantation: Kaplan–Meier versus Competing Risk Analysis model},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15298}
}
Start for free →